Blog

The Economic Case for Early Screening

As we  pave the way for better patient outcomes with the first minimally invasive microbiome-driven liquid biopsy technology, we also want to make sure that the important economic benefits that health insurance companies will reap from covering early cancer screening...

Micronoma Puts Machine Learning to Work

It’s no exaggeration to say the development of Micronoma’s Oncobiota™ microbiome-driven liquid-biopsy technology to detect cancer at an early stage would not be possible without extensive expertise and use of machine learning (ML) tools.  Micronoma’s proprietary...

Team Spotlight: Chuck Rosales, Quality Manager

Chuck Rosales joined Micronoma in July 2021 as the quality manager, responsible for implementing and maintaining all compliance and quality procedures to ensure that patient testing is performed with the highest standards. Though born in Kansas, he has lived in San...

Why is Clonal Evolution Still a Sterile Theory?

Despite major revelations in the science of cancer, a classic theory of how it develops—clonal evolution—has remained a perplexing vestige of ‘sterile’ cancer biology.  Arguing against the sterility of tumors, the last decade of research has revealed metabolically...

Hallmarks of Cancer Update Sharpens Focus on Micronoma’s Work

Inclusion of microbiome supports Micronoma’s efforts to improve cancer detection The “hallmarks of cancer” have captured the core features of cancer biology and served as a guide for future research since their original publication in Cell in 2000. Since then, the...

Team Spotlight: Gabriella Fanelli

Gabriella Fanelli, Executive Assistant Gabriella joined Micronoma in the Spring of 2021. Gabriella makes everything at Micronoma run smoothly and efficiently. As the only person on the team who’s not science-focused - she was an English literature major in college -...

Team Spotlight: Akanksha Singh-Taylor

Akanksha Singh-Taylor, Senior Scientist Akanksha Singh-Taylor joined Micronoma in September 2021 as a senior scientist on our wet lab side. Originally from Delhi, India, Akanksha moved to Houston when she was 10. During her work with children and adults with severe...

Cleaning Up Contamination Misconceptions 

While researchers have typically seen microbes only as contaminants and discarded them, Micronoma has set itself apart by seeing the treasure trove of opportunity microbes represent to detect and identify cancer early. Using liquid biopsy--a simple blood...

Team Spotlight: Darryl Garrison

Darryl Garrison, Chief Operating Officer Meet Darryl, our Chief Operating Officer. Darryl has more than 20 years of experience in the molecular diagnostic industry. He has been involved in setting up and running molecular clinical laboratories and has been responsible...

Team Spotlight: Serena Fraraccio

Serena Fraraccio, Senior Scientist Serena Fraraccio’s road to becoming Micronoma’s first wet lab senior scientist started in her hometown in Isernia, Italy, where an interest in the environment and biology blossomed into a career that has gone from winters in Alaska...

Cancer and the Microbiome: Now is the Time to Pay Close Attention

The recent realization that the microbiome impacts human health and disease states, as well as the rapid evolution of research tools has led to an exciting and critical juncture, when we can now go deeper than ever in understanding and using microbiome science for...

Team Spotlight: Eddie Adams

Eddie Adams, Chief Scientific Officer Eddie Adams has stacked up an impressive list of accomplishments and wealth of experience on his way to becoming Micronoma’s chief scientific officer (CSO), a role that enables him to combine his passion for solving problems with...

The Team Behind the Science

SepMicronoma’s founders each contribute unique skill sets and know-how to the company’s cutting-edge cancer detection platform.  For any team to be successful, each member must bring something unique to the table. At the same time, the individual pieces and parts must...

The Case for Tackling One Cancer at a Time

While having generated a lot of buzz recently, early screening for multiple types of cancer at once may not be that ideal in practice- the path to clinical adoption could be taking on one cancer type at a time. In a perfect world, a simple blood test would catch all...

The Cancer Microbiome Relationship

One of the most promising developments in cancer research originates with the microbiome If there is one area of cancer research that is causing a lot of excitement, it’s the link between the disease and the microbiome, and with good reason: it presents an opportunity...

What is the Microbiome?

In our bodies, to make our microbiome, we have more than 100 trillion microbes, including bacteria and viruses, outnumbering our normal cells by up to 10 to one. In fact, if you look at the genes in our bodies, we are only about 1% human, as most of our DNA is either...

Website Terms of Use, Privacy Policy, and Licenses

Micronoma, INC., CLIA #05D2253538

Oncobiota™ LDT is under development and is currently not available for commercial use in any jurisdiction. Once available under CLIA license, Oncobiota™ will be available in the United States by prescription only.

Contact Us

If you have questions or would like to learn more, please email us at info@micronoma.com or learn about joining our team at Careers.

Micronoma
6342 Ferris Square
San Diego, CA 92121